GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,443.00p
   
  • Change Today:
    -5.00p
  • 52 Week High: 1,767.00p
  • 52 Week Low: 1,264.00p
  • Currency: UK Pounds
  • Shares Issued: 4,099.70m
  • Volume: 2,137,512
  • Market Cap: £59,159m
  • RiskGrade: 129
  • Beta: 0.00

Other News

FTSE 100 preview: Greek delay hits shares 20-Jun-2011 This Is Money
GlaxoSmithKline gets green light over Potiga 14-Jun-2011 This Is Money

Irish zinc explorer Connemara Mining ...

11-Jun-2011 Proactive Investors
FTSE preview: Gloom over commodities 10-Jun-2011 This Is Money
FTSE preview: Shares hit by US jobs woe 06-Jun-2011 This Is Money
FTSE in-depth: Unilever up on £38bn bi... 01-Jun-2011 This Is Money
Newspaper and magazine share tips 24-May-2011 This Is Money
Midas: At last, Dogs are setting the pace 14-May-2011 This Is Money
How to enjoy the dividend revival 14-May-2011 This Is Money
Can you invest with a clear conscience? 10-May-2011 This Is Money
FTSE close: RBS, Capita up; miners rally 10-May-2011 This Is Money
FTSE 100 preview: US nerves knock shares 06-May-2011 This Is Money
FTSE preview: Shares to fall on profit-taking 04-May-2011 This Is Money
GlaxoSmithKline hit by cuts to spending 28-Apr-2011 This Is Money
FTSE preview: Shares wait on GDP & BP 27-Apr-2011 This Is Money
FTSE preview: Sluggish start after holiday 26-Apr-2011 This Is Money
City diary: Week ahead in the markets 21-Apr-2011 This Is Money
AstraZeneca to sell £1.3bn dental unit 17-Apr-2011 This Is Money
FTSE close: Next, Reckitt up; banks fall 15-Apr-2011 This Is Money
FTSE close: Banks, BP bounce; M&S, Dixon... 01-Apr-2011 This Is Money

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GSK Market Data

Currency UK Pounds
Share Price 1,443.00p
Change Today -5.00p
% Change -0.35 %
52 Week High 1,767.00p
52 Week Low 1,264.00p
Volume 2,137,512
Shares Issued 4,099.70m
Market Cap £59,159m
Beta 0.00
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
44.05% below the market average44.05% below the market average44.05% below the market average44.05% below the market average44.05% below the market average
23.40% above the sector average23.40% above the sector average23.40% above the sector average23.40% above the sector average23.40% above the sector average
Price Trend
13.86% above the market average13.86% above the market average13.86% above the market average13.86% above the market average13.86% above the market average
53.19% above the sector average53.19% above the sector average53.19% above the sector average53.19% above the sector average53.19% above the sector average
Income
74.90% above the market average74.90% above the market average74.90% above the market average74.90% above the market average74.90% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Growth
37.24% below the market average37.24% below the market average37.24% below the market average37.24% below the market average37.24% below the market average
48.39% below the sector average48.39% below the sector average48.39% below the sector average48.39% below the sector average48.39% below the sector average

What The Brokers Say

Strong Buy 4
Buy 2
Neutral 14
Sell 3
Strong Sell 1
Total 24
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q1 Q4
Ex-Div 15-May-25 20-Feb-25
Paid 10-Jul-25 10-Apr-25
Amount 16.00p 16.00p

Trades for --2025

Time Volume / Share Price
0 @ 0.000p

GSK Key Personnel

CEO Emma Walmsley

Top of Page